As breast marker, MGB has proven to be more sensitive than GCDFP-15, but is also expressed in other tumours, mainly in endometrial carcinomas, but rarely also in some sweat and salivary gland tumours, pancreatic and ovarian carcinomas and other tumours including some melanomas [9]. The gene discussed is PIP; the disease is neoplasm.